VirRx, Inc., is a biotechnology company with a primary interest in cancer gene therapy. Its broad mission is to develop genetically modified "smart bomb" adenoviruses for use in treating human cancers. Adenoviruses are ubiquitous, benign viruses that are one of the causes of the common cold. VirRx, ...

Summary VirRx is creating novel drugs to treat many different forms of human cancer. We have taken a common cold virus, named adenovirus, and changed some of its genes such that it will attack and destroy cancer tumors without harming normal tissues in the body. This modified virus is termed a "canc...